2020
DOI: 10.1016/j.radonc.2020.04.020
|View full text |Cite
|
Sign up to set email alerts
|

Automatic genetic planning for volumetric modulated arc therapy: A large multi-centre validation for prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 27 publications
0
10
0
Order By: Relevance
“…Even with the use of rectal spacer, the role of treatment planning is essential in delivering prescription dose to the prostate while meeting normal tissue tolerances. Advances in treatment planning over the past decade have enabled the radiation oncology community to reap the benefits of faster optimization and calculation times, automated planning processes, and higher accuracy in dose calculation 9–12 . Techniques that have long been researched have made their way into clinical implementation by way of commercial software.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Even with the use of rectal spacer, the role of treatment planning is essential in delivering prescription dose to the prostate while meeting normal tissue tolerances. Advances in treatment planning over the past decade have enabled the radiation oncology community to reap the benefits of faster optimization and calculation times, automated planning processes, and higher accuracy in dose calculation 9–12 . Techniques that have long been researched have made their way into clinical implementation by way of commercial software.…”
Section: Introductionmentioning
confidence: 99%
“…Advances in treatment planning over the past decade have enabled the radiation oncology community to reap the benefits of faster optimization and calculation times, automated planning processes, and higher accuracy in dose calculation. 9 , 10 , 11 , 12 Techniques that have long been researched have made their way into clinical implementation by way of commercial software. Knowledge‐based planning (KBP) and multicriteria optimization (MCO) are two recent advancements in inverse planning that have become commercially available through multiple vendors.…”
Section: Introductionmentioning
confidence: 99%
“…A dedicated application for breast autoplanning was also implemented in a commercial TPS [20,21]. Scripting in commercial TPS has also resulted in several clinical autoplanning applications [22,23]. Autoplanning has also been commercially implemented for so-called a posteriori multi-criterial optimization (MCO): automated generation of a Pareto front, followed by final plan selection by a planner using Pareto navigation [24][25][26][27].…”
mentioning
confidence: 99%
“…The accessibility of the merging platform opens the opportunities of the super-model to a wide set of users and allows centres with minimal experience or lack of data to use high-quality and well-tested super-models. Multi-centre validation of models has been common practice for a while [18] , [19] , [20] , and has shown that combining experience between centres can improve model performance and standardisation of radiotherapy [10] , [11] , [12] . Therefore, the ease with which multiple centres can contribute to and influence models plays an important role in improving radiotherapy treatment.…”
Section: Discussionmentioning
confidence: 99%